Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hospice pharmaceutical cost trends.

David Nowels1, Jean S Kutner, Cordt Kassner

  • 1Department of Family Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA.

The American Journal of Hospice & Palliative Care
|August 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Special Sauce: Lessons in Leadership Development from the Sojourns Scholar Leadership Program.

Journal of palliative medicine·2026
Same author

Joint Modeling of Quality of Life and Survival Using a Bayesian Approach in a Retrospective Time Scale.

Statistics in medicine·2026
Same author

Valued Living intervention to increase advance care planning and well-being in depressed and anxious adults with advanced cancer: Randomized trial in community oncology clinics.

Cancer·2026
Same author

The ASCENT Consortium: A New Resource to Support Palliative Care Science Across the Lifespan.

Journal of pain and symptom management·2026
Same author

Qualitative evaluation of an Accreditation Council for Graduate Medical Education-approved online hospice and palliative medicine fellowship program.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Developing and Testing a Program to Strengthen the Dementia Palliative Care Trial Workforce.

Journal of pain and symptom management·2026

Hospice pharmaceutical costs rose for most programs surveyed between 1998 and 2002, driven by factors like patient setting and specific drug types. Some hospices, however, achieved cost reductions through various control mechanisms.

Area of Science:

  • Health Services Research
  • Palliative Care
  • Pharmaceutical Economics

Background:

  • Hospices are mandated to cover pharmaceutical expenses through the Medicare Hospice Benefit.
  • Limited data exist on the financial impact of pharmaceuticals on hospice operations.
  • Understanding these costs is crucial for resource allocation and program sustainability.

Purpose of the Study:

  • To analyze pharmaceutical cost trends in hospice programs.
  • To identify factors influencing these cost trends.
  • To explore cost-control mechanisms utilized by hospices.

Main Methods:

  • A cross-sectional survey was conducted among 34 hospice programs.
  • Data were collected on pharmaceutical costs and related trends from 1998 to 2002.

Related Experiment Videos

  • Analysis focused on cost variations by patient setting and drug type.

    • Main Results:

    • A majority of surveyed hospices reported increased pharmaceutical costs during the study period.
    • A notable minority of hospices experienced decreased pharmaceutical costs.
    • Long-acting opioids and continuous-infusion delivery systems were identified as major cost drivers.
    • Pharmaceutical costs differed based on the patient's care setting.

    Conclusions:

    • Hospice pharmaceutical costs present a complex trend with varied experiences among programs.
    • Patient setting and specific high-cost medications significantly influence overall pharmaceutical expenditure.
    • Hospices employ diverse strategies to manage and control drug-related expenses effectively.